MCM
McKinley Capital Management Portfolio holdings
AUM
$571M
This Quarter Return
+14.59%
1 Year Return
+36.44%
3 Year Return
+63.31%
5 Year Return
+224.77%
10 Year Return
+727.77%
AUM
$833M
AUM Growth
+$833M
(+7%)
Cap. Flow
-$33.3M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
170
New
16
Increased
33
Reduced
83
Closed
7
Top Buys
| 1 |
HCA Healthcare
HCA
|
$3.05M |
| 2 |
GE HealthCare
GEHC
|
$3.04M |
| 3 |
Cooper Companies
COO
|
$2.51M |
| 4 |
Integer Holdings
ITGR
|
$2.2M |
| 5 |
Natera
NTRA
|
$2.1M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$13.4M |
| 2 |
Apple
AAPL
|
$4.42M |
| 3 |
Hims & Hers Health
HIMS
|
$4.04M |
| 4 |
NVIDIA
NVDA
|
$3.91M |
| 5 |
Humana
HUM
|
$2.78M |
Sector Composition
| 1 | Healthcare | 31.72% |
| 2 | Technology | 21.37% |
| 3 | Financials | 15.14% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
HealthStream
HSTM
$832M
| $3.55M | 0.43% |
133,110
| – | – |
|
77
McDonald's
MCD
$226B
| $3.55M | 0.43% |
12,578
+85
| +0.7% | +$24K |
|
78
HealthEquity
HQY
$8.26B
| $3.49M | 0.42% |
42,780
+8,320
| +24% | +$679K |
|
79
Evolent Health
EVH
$1.11B
| $3.48M | 0.42% |
106,100
| – | – |
|
80
Oaktree Specialty Lending
OCSL
$1.22B
| $3.21M | 0.39% |
163,205
-3,484
| -2% | -$68.5K |
|
|
81
HCA Healthcare
HCA
$95.4B
| $3.05M | 0.37% |
+9,140
| New | +$3.05M |
|
|
82
GE HealthCare
GEHC
$33B
| $3.04M | 0.36% |
+33,390
| New | +$3.04M |
|
83
Capital Southwest
CSWC
$1.27B
| $3.01M | 0.36% |
120,451
-2,097
| -2% | -$52.3K |
|
84
Avantor
AVTR
$8.74B
| $3M | 0.36% |
117,290
| – | – |
|
85
NeoGenomics
NEO
$1.06B
| $2.89M | 0.35% |
183,610
| – | – |
|
86
Goldman Sachs BDC
GSBD
$1.3B
| $2.83M | 0.34% |
189,179
-4,547
| -2% | -$68.1K |
|
87
Fortrea Holdings
FTRE
$971M
| $2.8M | 0.34% |
69,740
| – | – |
|
88
Carlyle Secured Lending
CGBD
$1.01B
| $2.71M | 0.33% |
166,285
-6,287
| -4% | -$102K |
|
89
Union Pacific
UNP
$132B
| $2.7M | 0.32% |
10,992
+10
| +0.1% | +$2.46K |
|
90
KKR & Co
KKR
$120B
| $2.62M | 0.32% |
26,083
+179
| +0.7% | +$18K |
|
|
91
Cooper Companies
COO
$13.3B
| $2.51M | 0.3% |
+24,710
| New | +$2.51M |
|
92
Exact Sciences
EXAS
$9.33B
| $2.49M | 0.3% |
36,070
| – | – |
|
93
Novo Nordisk
NVO
$252B
| $2.48M | 0.3% |
19,335
+8,751
| +83% | +$1.12M |
|
94
Southern Copper
SCCO
$82B
| $2.48M | 0.3% |
23,291
+322
| +1% | +$34.3K |
|
95
Medtronic
MDT
$118B
| $2.33M | 0.28% |
26,760
| – | – |
|
96
iRhythm Technologies
IRTC
$5.67B
| $2.31M | 0.28% |
19,940
| – | – |
|
97
Quest Diagnostics
DGX
$20.1B
| $2.28M | 0.27% |
17,110
-14,610
| -46% | -$1.94M |
|
98
Prospect Capital
PSEC
$1.34B
| $2.25M | 0.27% |
408,441
-13,080
| -3% | -$72.2K |
|
99
Novartis
NVS
$248B
| $2.23M | 0.27% |
23,069
+5,931
| +35% | +$574K |
|
|
100
Integer Holdings
ITGR
$3.71B
| $2.2M | 0.26% |
+18,860
| New | +$2.2M |
|